연구성과로 돌아가기

2024 연구자 정보 (425 / 1079)

※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Author Name 제1저자 여부 교신저자 여부 Address ResearcherID ORCID Paper Title WoS Edition 최상위 JCR(%) WoS Category Related Email
Kim, Young Keun
(Kim, YK)
Yonsei Univ, Wonju Coll Med, Dept Internal Med, Wonju, South Korea
Yonsei Univ, Wonju Coll Med, Dept Internal Med, Div Infect Dis, Wonju, South Korea
Yonsei Univ, Dept Internal Med, Coll Med, Wonju, South Korea
F-5424-2012
Kim, Young Hoon
0000-0002-2120-6265
Kim, Young Keun
[JCR상위 17.2] Estimates of vaccine effectiveness of the updated monovalent XBB.1.5 COVID-19 vaccine against symptomatic SARS-CoV-2 infection, hospitalization, and receipt of oxygen therapy in South Korea - October 26 to December 31, 2023
[JCR상위 34.6] Real-world effectiveness of influenza vaccine over a decade during the 2011-2021 seasons-Implications of vaccine mismatch
[JCR상위 62.5] Severe Fever with Thrombocytopenia Syndrome in South Korea, 2016-2021: Clinical Features of Severe Progression and Complications
SCIE 17.2 INFECTIOUS DISEASES
IMMUNOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH;TROPICAL MEDICINE
seran@yuhs.ac;
wjkim@korea.ac.kr;
hswon1@snu.ac.kr;
Kinsey, Matt
(Kinsey, M)
Johns Hopkins Univ, Appl Phys Lab, Baltimore, MD USA

[JCR상위 17.2] Challenges of COVID-19 Case Forecasting in the US, 2020-2021 SCIE 17.2 BIOCHEMICAL RESEARCH METHODS;MATHEMATICAL & COMPUTATIONAL BIOLOGY oko8@cdc.gov;
Kwon, Geun-Yong
(Kwon, GY)
Korea Dis Control & Prevent Agcy, Div Immunizat, Cheongju, South Korea

[JCR상위 17.2] Estimates of vaccine effectiveness of the updated monovalent XBB.1.5 COVID-19 vaccine against symptomatic SARS-CoV-2 infection, hospitalization, and receipt of oxygen therapy in South Korea - October 26 to December 31, 2023 SCIE 17.2 INFECTIOUS DISEASES seran@yuhs.ac;
Kwon, Jin-Won
(Kwon, JW)
교신저자 Kyungpook Natl Univ, Coll Pharm, BK21 FOUR Community Based Intelligent Novel Drug D, Daegu, South Korea
Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu, South Korea
Kyungpook Natl Univ, Daegu, South Korea
Kyungpook Natl Univ, Coll Pharm, BK21 FOUR Community Based Intelligent Novel Drug D, 80 Daehak Ro, Daegu 41566, South Korea
Kyungpook Natl Univ, Res Inst Pharmaceut Sci, 80 Daehak Ro, Daegu 41566, South Korea
Kyungpook Natl Univ, Coll Pharm, BK21 FOUR Community Based Intelligent Novel Drug D, Daegu 41566, South Korea
Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Daegu 41566, South Korea
Kyungpook Natl Univ, Coll Pharm, Brain Korea 21 Four Community Based Intelligent No, 80 Daehak Ro, Daegu 41566, South Korea
Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, 80 Daehak Ro, Daegu 41566, South Korea
Coll Pharm, BK21 FOUR Community Based Intelligent Novel Drug D, 80 Daehak Ro, Daegu 41566, South Korea
Res Inst Pharmaceut Sci, 80 Daehak Ro, Dae 41566, South Korea
Kyungpook Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, BK21 FOUR Community Based Intelligent Novel Drug D, 80,Daehakro, Daegu 41566, South Korea
Kyungpook Natl Univ, Res Inst Pharmaceut Sci, Coll Pharm, BK21 FOUR Community Based Intelligent Novel Drug D, 80 Daehakro, Daegu 41566, South Korea


[JCR상위 17.2] Incidence of tuberculosis disease in individuals diagnosed with tuberculosis infection after screening: A population-based cohort study in South Korea
[JCR상위 37.4] Impact of Medication Adherence to Active Tuberculosis Occurrence in Pediatric Population With Latent Tuberculosis Infection: A Population-Based Cohort Study In South Korea
[JCR상위 25.2] Influenza and the risk of active tuberculosis occurrence among individuals with latent tuberculosis infection: A national cohort study in South Korea (2015-2020)
[JCR상위 5.3] Exploiting mechanoregulation via FAK/YAP to overcome platinum resistance in ovarian cancer
[JCR상위 6.2] Information and Communications Technology-Based MonitoringService for Tailored Chronic Disease Management in PrimaryCare:Cost-Effectiveness Analysis Based on ICT-CM Trial Results
[JCR상위 11.2] Comparison of active tuberculosis occurrence associated with Janus kinase inhibitors and biological DMARDs in rheumatoid arthritis
[JCR상위 14.0] Assessing the Labeling Information on Drugs Associated With Suicide Risk: Systematic Review
[JCR상위 37.4] Effectiveness of Everolimus on Transplant Outcomes in Korean Liver Transplant Recipients: A Nationwide Cohort Study
[JCR상위 37.4] Severe Cutaneous Adverse Reactions Associated with Antibiotics in Pediatric Patients
[JCR상위 0.8] Long-term cardiovascular risk reduction after gastric cancer surgery: a nationwide cohort study
[JCR상위 9.5] Discontinuation of blood pressure-lowering, glucose-lowering, and lipid-lowering medications after bariatric surgery in patients with morbid obesity: a nationwide cohort study in South Korea
SCIE
SCIE;SSCI
0.8 INFECTIOUS DISEASES
PHARMACOLOGY & PHARMACY;PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
IMMUNOLOGY;INFECTIOUS DISEASES;MICROBIOLOGY
MEDICINE, RESEARCH & EXPERIMENTAL;PHARMACOLOGY & PHARMACY
HEALTH CARE SCIENCES & SERVICES;MEDICAL INFORMATICS
RHEUMATOLOGY
PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH
SURGERY
jwkwon@knu.ac.kr;
jaelee@knu.ac.kr;seohw@knu.ac.kr;gj1705@naver.com;hjs04090409@gmail.com;jwkwon@knu.ac.kr;
sypark20@kmu.ac.kr;
kwon.yeongkeun@gmail.com;gj1705@naver.com;socalman64@naver.com;janeha0124@gmail.com;hjs04090409@gmail.com;kugspss@korea.ac.kr;jwkwon@knu.ac.kr;
Ladd, Mary A.
(Ladd, MA)
Massachusetts Gen Hosp, Boston, MA USA

[JCR상위 17.2] Challenges of COVID-19 Case Forecasting in the US, 2020-2021 SCIE 17.2 BIOCHEMICAL RESEARCH METHODS;MATHEMATICAL & COMPUTATIONAL BIOLOGY oko8@cdc.gov;
Lavista Ferres, Juan
(Ferres, JL)
Microsoft, Redmond, WA USA

[JCR상위 17.2] Challenges of COVID-19 Case Forecasting in the US, 2020-2021 SCIE 17.2 BIOCHEMICAL RESEARCH METHODS;MATHEMATICAL & COMPUTATIONAL BIOLOGY oko8@cdc.gov;
Le, Khoa
(Le, K)
Univ Massachusetts, Amherst, MA USA

[JCR상위 17.2] Challenges of COVID-19 Case Forecasting in the US, 2020-2021 SCIE 17.2 BIOCHEMICAL RESEARCH METHODS;MATHEMATICAL & COMPUTATIONAL BIOLOGY oko8@cdc.gov;
Lee, Dong Yeup
(Lee, DY)
Catholic Univ, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea

[JCR상위 17.2] Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab SCIE 17.2 IMMUNOLOGY tmznjf@catholic.ac.kr;pssung49@gmail.com;
Lee, Elizabeth C.
(Lee, EC)
Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA H-6508-2019
Lee, Elizabeth

[JCR상위 17.2] Challenges of COVID-19 Case Forecasting in the US, 2020-2021 SCIE 17.2 BIOCHEMICAL RESEARCH METHODS;MATHEMATICAL & COMPUTATIONAL BIOLOGY oko8@cdc.gov;
Lee, Jaejun
(Lee, J)
제1저자 Catholic Univ, Liver Res Ctr, Coll Med, Dept Biomed & Hlth Sci, Seoul, South Korea
Catholic Univ, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea
Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Hepatol,Dept Internal Med, Seoul, South Korea


[JCR상위 17.2] Prognostic significance of combined PD-L1 expression in malignant and infiltrating cells in hepatocellular carcinoma treated with atezolizumab and bevacizumab
[JCR상위 37.6] Improved survival with second-line hepatic arterial infusion chemotherapy after atezolizumab-bevacizumab failure in hepatocellular carcinoma
SCIE 17.2 IMMUNOLOGY
ONCOLOGY
tmznjf@catholic.ac.kr;pssung49@gmail.com;
oj-cumc@daum.net;pssung@catholic.ac.kr;
Lee, Ji Hyuk
(Lee, JH)
Chungbuk Natl Univ, Coll Med, Dept Pediat, Chungju, South Korea

[JCR상위 17.2] Comparison of endoscopic healing and durability between infliximab originator and CT-P13 in pediatric patients with inflammatory bowel disease SCIE 17.2 IMMUNOLOGY benkang@knu.ac.kr;
Lee, Jin-Soo
(Lee, JS)
Inha Univ, Coll Med, Dept Internal Med, Div Infect Dis, Incheon, South Korea
Inha Univ, Sch Med, Dept Internal Med, Div Infect Dis, Incheon, South Korea


[JCR상위 17.2] Estimates of vaccine effectiveness of the updated monovalent XBB.1.5 COVID-19 vaccine against symptomatic SARS-CoV-2 infection, hospitalization, and receipt of oxygen therapy in South Korea - October 26 to December 31, 2023
[JCR상위 37.6] Recommendations for Adult Immunization by the Korean Society of Infectious Diseases, 2023: Minor Revisions to the 3rd Edition
[JCR상위 34.6] Real-world effectiveness of influenza vaccine over a decade during the 2011-2021 seasons-Implications of vaccine mismatch
SCIE
ESCI
17.2 INFECTIOUS DISEASES
IMMUNOLOGY;MEDICINE, RESEARCH & EXPERIMENTAL
seran@yuhs.ac;
heejinmd@korea.ac.kr;
wjkim@korea.ac.kr;
Lee, Jung Ah
(Lee, JA)
제1저자 Yonsei Univ, Coll Med, Dept Internal Med, Div Infect Dis, Seoul, South Korea
0000-0001-9891-5134
LEE, JUNG AH
[JCR상위 17.2] Estimates of vaccine effectiveness of the updated monovalent XBB.1.5 COVID-19 vaccine against symptomatic SARS-CoV-2 infection, hospitalization, and receipt of oxygen therapy in South Korea - October 26 to December 31, 2023 SCIE 17.2 INFECTIOUS DISEASES seran@yuhs.ac;
Lee, Kunsong
(Lee, KS)
Dankook Univ, Coll Med, Dept Pediat, Cheonan, South Korea MIO-6255-2025
Lee, KyungJae

[JCR상위 17.2] Comparison of endoscopic healing and durability between infliximab originator and CT-P13 in pediatric patients with inflammatory bowel disease SCIE 17.2 IMMUNOLOGY benkang@knu.ac.kr;
Lee, Se Ju
(Lee, SJ)
Inha Univ, Coll Med, Dept Internal Med, Div Infect Dis, Incheon, South Korea KMX-1267-2024
LEE, SEJUE

[JCR상위 17.2] Estimates of vaccine effectiveness of the updated monovalent XBB.1.5 COVID-19 vaccine against symptomatic SARS-CoV-2 infection, hospitalization, and receipt of oxygen therapy in South Korea - October 26 to December 31, 2023 SCIE 17.2 INFECTIOUS DISEASES seran@yuhs.ac;
페이지 이동: